Join the Insulin Lispro group to help and get support from people like you.
Insulin Lispro News
Eli Lilly Reports Temporary Shortage of Humalog and Insulin Lispro Injection
MONDAY, March 25, 2024 – Eli Lilly & Co. announced on Friday a temporary shortage of two of its insulin products. "The 10 mL vials of Humalog and Insulin Lispro Injection are or will be temporarily...
Eli Lilly Warns That 2 Insulin Products Will Be in Short Supply
MONDAY, March 25, 2024 – Drugmaker Eli Lilly & Co is announcing a temporary shortage of two of its insulin products. "The 10 mL [millilter] vials of Humalog® and Insulin Lispro Injection are or will ...
FDA Clears New Insulin Pump and Algorithm-Based Software to Support Enhanced Automatic Insulin Delivery
May 19, 2023 – Today, the U.S. Food and Drug Administration cleared the Beta Bionics iLet ACE Pump and the iLet Dosing Decision Software for people six years of age and older with type 1 diabetes....
Lyumjev (insulin lispro-aabc) Injection Approved by U.S. FDA for Children with Diabetes
October 14, 2022 – The U.S. Food and Drug Administration (FDA) approved an expansion of the indication for Eli Lilly and Company's rapid-acting mealtime insulin Lyumjev® (insulin lispro-aabc) ...
FDA Approves Lyumjev (insulin lispro-aabc injection) 100 units/mL for Use in Insulin Pumps
INDIANAPOLIS, Aug. 16, 2021 /PRNewswire/ – The U.S. Food and Drug Administration (FDA) has approved an expanded label for Eli Lilly and Company's (NYSE: LLY) rapid-acting insulin, Lyumjev (insulin...
FDA Approves Lyumjev (insulin lispro-aabc injection) for Type 1 and Type 2 Diabetes
INDIANAPOLIS, June 15, 2020 /PRNewswire/ – The U.S. Food and Drug Administration (FDA) has approved Lyumjev (insulin lispro-aabc injection, 100 units/mL and 200 units/mL), Eli Lilly and Company's...
FDA Medwatch Alert: Caution When Using Pen Needles to Inject Medicines: FDA Safety Communication
Audience: Patients and caregivers who use or are considering using pen injectors with pen needles to inject prescription medicines. Health care providers who treat patients, or who train...
FDA Approves Admelog (insulin lispro) Rapid-Acting "Follow-On" Insulin Product to Treat Diabetes
December 11, 2017 – The U.S. Food and Drug Administration today approved Admelog (insulin lispro injection), a short-acting insulin indicated to improve control in blood sugar levels in adults and...
Ask a question
To post your own question to this support group, sign in or create an account.
Further information
Related condition support groups
Diabetes, Type 2, Diabetes, Type 1